205 related articles for article (PubMed ID: 8608226)
1. Abnormal inside-out signal transduction-dependent activation of glycoprotein IIb-IIIa in a patient with impaired pleckstrin phosphorylation.
Gabbeta J; Yang X; Sun L; McLane MA; Niewiarowski S; Rao AK
Blood; 1996 Feb; 87(4):1368-76. PubMed ID: 8608226
[TBL] [Abstract][Full Text] [Related]
2. Combined defect in membrane expression and activation of platelet GPIIb--IIIa complex without primary sequence abnormalities in myeloproliferative disease.
Kaplan R; Gabbeta J; Sun L; Mao GF; Rao AK
Br J Haematol; 2000 Dec; 111(3):954-64. PubMed ID: 11122160
[TBL] [Abstract][Full Text] [Related]
3. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity.
Hu H; Zhang W; Li N
J Thromb Haemost; 2003 Aug; 1(8):1805-12. PubMed ID: 12911597
[TBL] [Abstract][Full Text] [Related]
4. Association of CBFA2 mutation with decreased platelet PKC-theta and impaired receptor-mediated activation of GPIIb-IIIa and pleckstrin phosphorylation: proteins regulated by CBFA2 play a role in GPIIb-IIIa activation.
Sun L; Mao G; Rao AK
Blood; 2004 Feb; 103(3):948-54. PubMed ID: 14525764
[TBL] [Abstract][Full Text] [Related]
5. [Conformational changes of the platelet membrane glycoprotein IIb-IIIa complex stimulated by a monoclonal antibody to the N-terminal segment of glycoprotein IIIa].
Khaspekova SG; Vyzova TV; Lukin VV; Tikhomirov OIu; Berndt M; Kouns W; Mazurov AV
Biokhimiia; 1996 Mar; 61(3):412-28. PubMed ID: 8724599
[TBL] [Abstract][Full Text] [Related]
6. A Glanzmann thrombasthenia-like phenotype caused by a defect in inside-out signaling through the integrin alpha(IIb)beta3.
Tomiyama Y; Shiraga M; Kinoshita S; Ambo H; Kurata Y; Matsuzawa Y; Kunicki TJ
Thromb Haemost; 1998 Nov; 80(5):735-42. PubMed ID: 9843164
[TBL] [Abstract][Full Text] [Related]
7. Selective induction of a glycoprotein IIIa ligand-induced binding site by fibrinogen and von Willebrand factor.
Mondoro TH; Wall CD; White MM; Jennings LK
Blood; 1996 Nov; 88(10):3824-30. PubMed ID: 8916946
[TBL] [Abstract][Full Text] [Related]
8. Analysis of platelet aggregation disorders based on flow cytometric analysis of membrane glycoprotein IIb-IIIa with conformation-specific monoclonal antibodies.
Ginsberg MH; Frelinger AL; Lam SC; Forsyth J; McMillan R; Plow EF; Shattil SJ
Blood; 1990 Nov; 76(10):2017-23. PubMed ID: 2242424
[TBL] [Abstract][Full Text] [Related]
9. Human platelet signaling defect characterized by impaired production of inositol-1,4,5-triphosphate and phosphatidic acid and diminished Pleckstrin phosphorylation: evidence for defective phospholipase C activation.
Yang X; Sun L; Ghosh S; Rao AK
Blood; 1996 Sep; 88(5):1676-83. PubMed ID: 8781423
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin complements G(i)- but not G(q)-dependent pathways for integrin {alpha}(IIb){beta}(3) activation and platelet aggregation.
Campus F; Lova P; Bertoni A; Sinigaglia F; Balduini C; Torti M
J Biol Chem; 2005 Jul; 280(26):24386-95. PubMed ID: 15863506
[TBL] [Abstract][Full Text] [Related]
11. The P2Y(12) receptor induces platelet aggregation through weak activation of the alpha(IIb)beta(3) integrin--a phosphoinositide 3-kinase-dependent mechanism.
Kauffenstein G; Bergmeier W; Eckly A; Ohlmann P; Léon C; Cazenave JP; Nieswandt B; Gachet C
FEBS Lett; 2001 Sep; 505(2):281-90. PubMed ID: 11566191
[TBL] [Abstract][Full Text] [Related]
12. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
Wang WY; Wu YC; Wu CC
Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
[TBL] [Abstract][Full Text] [Related]
13. Induction of fibrinogen binding and platelet aggregation as a potential intrinsic property of various glycoprotein IIb/IIIa (alphaIIbbeta3) inhibitors.
Peter K; Schwarz M; Ylänne J; Kohler B; Moser M; Nordt T; Salbach P; Kübler W; Bode C
Blood; 1998 Nov; 92(9):3240-9. PubMed ID: 9787160
[TBL] [Abstract][Full Text] [Related]
14. Glycoprotein IIb Leu214Pro mutation produces glanzmann thrombasthenia with both quantitative and qualitative abnormalities in GPIIb/IIIa.
Grimaldi CM; Chen F; Wu C; Weiss HJ; Coller BS; French DL
Blood; 1998 Mar; 91(5):1562-71. PubMed ID: 9473221
[TBL] [Abstract][Full Text] [Related]
15. Von Willebrand factor can support platelet aggregation via interaction with activated GPIIb-IIIa and GPIb.
Naimushin YA; Mazurov AV
Platelets; 2004 Nov; 15(7):419-25. PubMed ID: 15745313
[TBL] [Abstract][Full Text] [Related]
16. Synergistic outside-in regulation of platelet activation by GPIIb/IIIa ligand-induced conformation and oligomerization.
Wang XF; Liu F; Morris SA; Carroll RC
Thromb Res; 2001 Nov; 104(4):239-47. PubMed ID: 11728525
[TBL] [Abstract][Full Text] [Related]
17. Coordinated signaling through both G12/13 and G(i) pathways is sufficient to activate GPIIb/IIIa in human platelets.
Dorsam RT; Kim S; Jin J; Kunapuli SP
J Biol Chem; 2002 Dec; 277(49):47588-95. PubMed ID: 12297512
[TBL] [Abstract][Full Text] [Related]
18. Differential inhibition of fibrinogen binding to agonist- and RGDS peptide-activated states of GPIIb-IIIa by an anti-GPIIIa monoclonal antibody, PMA5.
Nakatanl S; Hato T; Minamoto Y; Fujita S
Thromb Haemost; 1996 Dec; 76(6):1030-7. PubMed ID: 8972028
[TBL] [Abstract][Full Text] [Related]
19. Human platelet activation is inhibited by the occupancy of glycoprotein IIb/IIIa receptor.
Padoin E; Alexandre A; Cavallini L; Polverino de Laureto P; Rao GH; Doni MG
Arch Biochem Biophys; 1996 Sep; 333(2):407-13. PubMed ID: 8809080
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase C- and calcium-regulated pathways independently synergize with Gi pathways in agonist-induced fibrinogen receptor activation.
Quinton TM; Kim S; Dangelmaier C; Dorsam RT; Jin J; Daniel JL; Kunapuli SP
Biochem J; 2002 Dec; 368(Pt 2):535-43. PubMed ID: 12215172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
